Early biomarkers of stroke

Clinical Chemistry

Volumn 49, Issue 10, 2003, Pages 1733-1739

  Reynolds, Mark A ^a   Kirchick, Howard J ^a   Dahlen, Jeffrey R ^a   Anderberg, Joseph M ^a   McPherson, Paul H ^a   Nakamura, Kevin K ^a   Laskowitz, Daniel T ^b   Valkirs, Gunars E ^a   Buechler, Kenneth F ^a  

^a Biosite Incorporated   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTROPHIC GROWTH FACTOR BETA; PROTEIN S100B; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ALGORITHM; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; SAMPLING; STROKE;

ACUTE DISEASE; BIOLOGICAL MARKERS; BLOOD PROTEINS; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBROVASCULAR ACCIDENT; CHEMOKINE CCL2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTRACRANIAL HEMORRHAGES; MATRIX METALLOPROTEINASE 9; NERVE GROWTH FACTORS; PROGNOSIS; REGRESSION ANALYSIS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; VON WILLEBRAND FACTOR;

EID: 0141504212     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.10.1733     Document Type: Conference Paper

References (15)

1. Hanley D. Review of critical care and emergency approaches to stroke. Stroke 2003;34:362-4.
2. Kent D, Ruthazer R, Selker H. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke 2003;34:464-7.
3. Schellinger P, Fiebach J, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 2003;34:575-83.
4. Belayev L, Busto R, Zhao W, Ginsberg MD. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 1996;739:88-96.
5. Merten CL, Knitelius HO, Assheuer J, Bergmann-Kurz B, Hedde JP, Bewermeyer J. MRI of acute cerebral infarcts, increased contrast enhancement with continuous infusion of gadolinium. Neuroradiology 1999;41:242-8.
6. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997;28:1956-60.
7. Martens P, Raabe A, Johnsson P. Serum S-100 and neuronspecific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998;29:2363-6.
8. Shozuhara H, Onodera H, Katoh-Semba R, Kato K, Yamasaki Y, Kogure K. Temporal profiles of nerve growth factor β-subunit level in rat brain regions after transient ischemia. J Neurochem 1992;59:175-80.
9. Abe K. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cereb Blood Flow Metab 2000;20:1393-408.
10. McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 2002;51:1128-34,discussion 1134-5.
11. Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003;34:40-6.
12. Losy J, Zaremba J. Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 2001;32:2695-6.
13. Buechler J, Valkirs G, Gray J, inventors. Biosite Diagnostics Inc., assignee. Polyvalent display libraries. US Patent No. 6,057,098, May 2, 2000.
14. Ng SM, Krishnaswamy P, Morissey R, Clopton P, Fitzgerald R, Maisel AS. Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol 2001;88:611-7.
15. Wardlaw JM, Dorman PJ, Lewis SC, Sandercock PA. Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT? J Neurol Neurosurg Psychiatry 1999;67:651-3.